WASHINGTON, Nov 23 (Reuters) - The U.S. Senate Judiciary
Committee on Monday postponed a hearing planned for next week to
discuss Mylan NV's pending $465 million settlement to
resolve charges that it underpaid government healthcare programs
by misclassifying its EpiPen emergency allergy treatment.
Read more
No comments:
Post a Comment